Based on 13 studies, the meta-analysis revealed loneliness and social isolation were associated with increased all-cause mortality (hazard ratio, 1.34; P < 0.001) and cancer-specific mortality (hazard ...

Researchers have identified a pattern of longer overall survival in patients with stage IV rectal SCC than among patients with stage IV colon SCC.

For patients with metastatic primary pNETs, resection is associated with improved survival outcomes but also linked to perioperative complications.

Younger patients with neuroendocrine tumors have worse symptom burden health-related quality of life than older patients, researchers report.

CAPTEM (capecitabine and temozolomide) provided a high rate of disease control in patients with typical and atypical lung ...

The Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory ...

(HealthDay News) — The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs. The move is part of a Trump administration program aimed at ...

Adding immunotherapy to chemotherapy can improve survival in patients with metastatic, poorly differentiated GEP-NECs, data suggest.

New research suggests that, among patients with neuroendocrine tumors, primary tumor sites differ by race, and overall survival outcomes differ by tumor site and gender.

We recommend that CTC should be routinely assessed and measured at diagnosis as part of risk evaluation,” study researchers wrote.

Phase 3 ARENSENS clinical trial results were presented at JADPRO 2025, indicating darolutamide plus ADT improved rPFS in prostate cancer.

Incidence and mortality from renal cancer may double by 2050, according to a study published in European Urology.